Medical illness and schizophrenia /

Por Meyer, Jonathan M., Nasrallah, Henry A.
Publicado em 2003

Moving Ahead with the Schizophrenia Concept: From the Elephant to the Mouse

Por Keshavan, Matcheri S, Nasrallah, Henry A, Tandon, Rajiv
Publicado em 2011

Suicide Note Classification Using Natural Language Processing: A Content Analysis

Por Pestian, John, Nasrallah, Henry, Matykiewicz, Pawel, Bennett, Aurora, Leenaars, Antoon
Publicado em 2010

NEW DRUG DEVELOPMENTS IN PSYCHOSIS: CHALLENGES, OPPORTUNITIES AND STRATEGIES

Por Keshavan, Matcheri S., Lawler, Ashley N., Nasrallah, Henry A., Tandon, Rajiv
Publicado no Prog Neurobiol (2016)

Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole

Por Shertzer, Howard G., Kendig, Eric L., Nasrallah, Henry A., Johansson, Elisabet, Genter, Mary Beth
Publicado em 2010

Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies

Por Nasrallah, Henry A., Cucchiaro, Josephine B., Mao, Yongcai, Pikalov, Andrei A., Loebel, Antony D.
Publicado no CNS Spectr (2014)

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Por Durgam, Suresh, Landbloom, Ronald P, Mackle, Mary, Wu, Xiao, Mathews, Maju, Nasrallah, Henry A
Publicado no Neuropsychiatr Dis Treat (2017)

Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil

Por Nasrallah, Henry A., Aquila, Ralph, Stanford, Arielle D., Jamal, Hasan H., Weiden, Peter J., Risinger, Robert
Publicado no Psychopharmacol Bull (2017)

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review

Por Serafini, Gianluca, Adavastro, Giulia, Canepa, Giovanna, De Berardis, Domenico, Valchera, Alessandro, Pompili, Maurizio, Nasrallah, Henry, Amore, Mario
Publicado no Int J Mol Sci (2018)

The Standard for Clinicians’ Interview in Psychiatry (SCIP): A Clinician-administered Tool with Categorical, Dimensional, and Numeric Output—Conceptual Development, Design, and Des...

Por Aboraya, Ahmed, Nasrallah, Henry, Muvvala, Srinivas, El-Missiry, Ahmed, Mansour, Hader, Hill, Cheryl, Elswick, Daniel, Price, Elizabeth C.
Publicado no Innov Clin Neurosci (2016)

17. Effects of Cariprazine on Negative Symptoms, Cognitive Impairment, and Prosocial Functioning in Patients With Predominant Negative Symptoms: Post Hoc Analysis of a Phase III, P...

Por Daniel, David, Nasrallah, Henry, Earley, Willie, Durgam, Suresh, Lu, Kaifeng, Szatmári, Balázs, Laszlovszky, István, Németh, György, Patel, Mehul
Publicado no Schizophr Bull (2017)

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

Por Nasrallah, Henry A., Earley, Willie, Cutler, Andrew J., Wang, Yao, Lu, Kaifeng, Laszlovszky, István, Németh, György, Durgam, Suresh
Publicado no BMC Psychiatry (2017)

A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia

Por Nasrallah, Henry A, Gopal, Srihari, Gassmann-Mayer, Cristiana, Quiroz, Jorge A, Lim, Pilar, Eerdekens, Mariëlle, Yuen, Eric, Hough, David
Publicado em 2010

Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases

Por Lasser, Robert A, Dirks, Bryan, Nasrallah, Henry, Kirsch, Courtney, Gao, Joseph, Pucci, Michael L, Knesevich, Mary A, Lindenmayer, Jean-Pierre
Publicado em 2013

The Association Between Weight Change And Symptom Reduction in the CATIE Schizophrenia Trial

Por Hermes, Eric, Nasrallah, Henry, Davis, Vicki, Meyer, Jonathan, McEvoy, Joseph, Goff, Donald, Davis, Sonia, Stroup, Scott, Swartz, Marvin, Lieberman, Jeffrey, Rosenheck, Robert
Publicado em 2011

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics

Por McEvoy, Joseph, Baillie, Rebecca A., Zhu, Hongjie, Buckley, Peter, Keshavan, Matcheri S., Nasrallah, Henry A., Dougherty, George G., Yao, Jeffrey K., Kaddurah-Daouk, Rima
Publicado em 2013

Measurement-based Care in Psychiatry—Past, Present, and Future

Por Aboraya, Ahmed, Nasrallah, Henry A., Elswick, Daniel E., Ahmed, Elshazly, Estephan, Nevine, Aboraya, Dalia, Berzingi, Seher, Chumbers, Josleen, Berzingi, Sara, Justice, John, Zafar, Jawad, Dohar, Sheena
Publicado no Innov Clin Neurosci (2018)

Recent Advances in Understanding and Mitigating Adipogenic and Metabolic Effects of Antipsychotic Drugs

Por Gohlke, Julia M., Dhurandhar, Emily J., Correll, Christoph U., Morrato, Elaine H., Newcomer, John W., Remington, Gary, Nasrallah, Henry A., Crystal, Stephen, Nicol, Ginger, Allison, David B.
Publicado em 2012

Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized co...

Por Stroup, T. Scott, Byerly, Matthew J., Nasrallah, Henry A., Ray, Neepa, Khan, Ahsan Y., Lamberti, J. Steven, Glick, Ira D., Steinbook, Richard M., McEvoy, Joseph P., Hamer, Robert M.
Publicado em 2013

Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the CATIE Schizophrenia Trial

Por Meyer, Jonathan M., McEvoy, Joseph P., Davis, Vicki G., Goff, Donald C., Nasrallah, Henry A., Davis, Sonia M., Hsiao, John K., Swartz, Marvin S., Stroup, T. Scott, Lieberman, Jeffrey A.
Publicado em 2009